Skip to content

Sepsis and Hospital Mortality

Sepsis Mortality in Hospitals: a Quality Indicator in Acute Care Settings

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07022041
Enrollment
100
Registered
2025-06-15
Start date
2025-07-15
Completion date
2026-12-15
Last updated
2025-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Brief summary

Sepsis is one of the leading causes of hospital mortality, with a rate of approximately 20% (World Health Organization) among vulnerable patients admitted to high-intensity care units such as CCUs and inpatient wards. Currently, diagnostic criteria such as the Systemic Inflammatory Response Syndrome (SIRS) and the Sequential Organ Failure Assessment (SOFA) score, although widely used, lack sufficient specificity and accuracy. No established parameters are available for early and timely diagnosis. This study aims to address this gap by investigating the variability of blood plasma conductivity and dielectric constant using microwave probes previously validated for non-invasive glucose monitoring. The acquired data will be analyzed using the Anritsu VectorStar VNA to identify innovative and reliable parameters associated with the presence of severe infections.

Interventions

DIAGNOSTIC_TESTconductivity and dieletric constant

collecting blood samples and directly measuring plasma conductivity and dielectric constant using microwave probes already validated for non-invasive glucose monitoring.

Sponsors

University of Calabria
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years * Cardiology patients without documented infection (Control Group) * Patients with sepsis * Patients with nosocomial infection * Patients with myocarditis, endocarditis, or pericarditis * Ability to provide written informed consent

Exclusion criteria

* Patients with severe or chronic medical conditions that may interfere with study results, such as autoimmune diseases, renal or hepatic failure * Patients taking medications that could affect the measured biophysical parameters, such as corticosteroids or immunosuppressants * Patients with cancer * Patients with diseases involving the immune system (e.g., lymphomas, leukemias) * Patients with congenital or acquired immunodeficiencies (e.g., HIV) * Patients who are unable to read and sign the informed consent form

Design outcomes

Primary

MeasureTime frameDescription
Comparative Analysis of Plasma Bioelectrical Properties in Sepsisthrough study completion, an average of 10 daysdifferences in blood plasma conductivity and dielectric constant will be analyzed between patients with and without sepsis, using validated microwave probes and appropriate statistical methods.

Secondary

MeasureTime frameDescription
Correlation Between Biophysical Parameters and Conventional Infection and Inflammation Biomarkersthrough study completion, an average of 3 monthscorrelations will be assessed between measured biophysical parameters and conventional infection/inflammation biomarkers (e.g., ESR, procalcitonin, CRP, and white blood cell count) in patients with suspected or confirmed infection.

Countries

Italy

Contacts

Primary ContactAntonio Curcio, Medicine
antonio.curcio.cardio@unical.it+390984681877

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026